Functional movement disorders: Successful treatment with a physical therapy rehabilitation protocol
Introduction
Functional movement disorders (FMD) are characterized by abnormal motor behaviors that are inconsistent with an organic etiology. These may resemble organic tremor, dystonia, other hyperkinetic conditions, gait disorders, paresis or combinations. These may account for 3% [1] to 15% [2] of patients seen by neurology movement disorder specialists but are also common in general neurology clinics.
These conditions are often categorized as “psychogenic”, and this term is sometimes used interchangeably with “functional”. The lay-dictionary defines “psychogenic” as, “originating in the mind or in mental or emotional conflict.” [3]. This obviously implies a primary psychological cause and this may not be strictly applicable to many patients. Moreover, telling patients their life-altering disorder is “psychogenic,” with all the implications, may sabotage the working relationship with the clinician. In this manuscript, we will avoid that term, preferring “functional”.
Once diagnosed, FMD present an enormous therapeutic challenge. Prognosis is often characterized as poor, with most patients failing to substantially improve, especially among those with symptoms persistent beyond one year [4], [5], [6]. Even among series that are more optimistic, substantial numbers of patients have persistent disability [2].
With the notoriety accorded similar disorders by Freud more than a century ago [7], therapeutic strategies have focused especially on psychiatric/psychological interventions. In the current era, psychotherapy, antidepressant and other psychoactive medications are typically an early treatment approach [8], [9], [10]. Although many publications have attested to the benefits of psychotherapeutic and other psychological/psychiatric strategies, our experience has not been as gratifying, and the pessimistic outcomes from movement clinics are consistent with that perception [4], [5], [6].
Physical therapy has also been advocated for such patients, although specific strategies have been left to individual treating therapists [11]. In our experience many of these patients have already undergone physical therapy, but failed to substantially benefit; thus, generic physical therapy in the absence of a specific treatment-program has not been successful.
In fact, there is no consensus about treatment of FMD [12]. Clinicians generally find this to be a very unsatisfying aspect of their practice, with frustration among both patients and physicians. This was our collective experience for many years; we could diagnose, but not effectively treat.
A number of years ago, we recognized that functional speech/voice disorders were highly responsive to a behavioral motor re-programming approach by our Mayo Speech-Language Pathology colleagues [13], [14]. In fact, a parallel approach was being used successfully, but inconsistently in our Physical Medicine and Rehabilitation (PMR) Department as treatment for FMD. Encouraged by these outcomes, we developed a more structured motor-reprogramming treatment protocol for FMD patients implemented in the PMR Department.
Such motor-reprogramming in the context of physical medicine has been used for treatment of FMD with limited precedents [15], [16]. The approach involves specifically focusing on the aberrant movements and postures, breaking these down into the individual motor components and gradually reconstructing more normal motor patterns. With this strategy, appropriate motor pattens are reinforced and inappropriate movements are ignored (extinguished). By gradually rebuilding or re-shaping motor movements, more normal pattens can be achieved. Our initial treatment protocol arbitrarily confined this to one intensive week of twice-daily physical and occupational therapy, after the physiatrist had initially designed the therapy program for that patient. Our initial experience suggested that one week was sufficient. This has been utilized as the primary therapeutic strategy for the treatment of FMD patients diagnosed in our movement disorders clinic since 2005.
We now describe our experience with the first 60 consecutive patients who were diagnosed with an FMD in our Neurology Department and subsequently treated with this approach. This was exclusively designed as a therapeutic PMR protocol for the benefit of our patients, and we had no a-priori plan to formally study/report the outcomes. The initial follow-up called for reassessment only at the end of the treatment week. As substantial efficacy became apparent, we elected to better assess outcomes, which included adding phone- and letter-follow-up to tabulate longer-term responses. For comparison we also included a control-group of patients who were similarly diagnosed, but not treated with this approach.
Section snippets
Study-design
For this historical-cohort-study, we retrospectively identified from our Mayo computer-database all patients who had been evaluated between 1/1/2005 and 12/31/2008 in the Mayo Clinic Department of Neurology and given a final diagnosis of an FMD. These included varied functional motor disorders: gait, tremor, other hyperkinetic movements, or paresis. From this group we then identified all those subsequently treated during this period in the Mayo PMR Department utilizing this motor-reprogramming
Demographics (Table 1)
The mean age of the 60 patients in the treatment cohort was 46 years (range 17–79), with female predominance (76.7%) and median symptom duration, 17 months (range 1–276). Most patients (95%) were seen for a second neurological opinion and 45% were either unemployed or work-disabled at time of evaluation.
Patients had previously carried a diagnosis of a neurologic disorder (42.1%), conversion disorder (24.6%) or indeterminate disorder (33.3%) and underwent prior unsuccessful treatment trials with
Discussion
Patients in the PMR treatment group presented with long durations of functional movement problems (median duration, 17.5 months), and hence the outcomes at the end of the PMR week were quite notable: approximately 70% were rated as markedly improved, nearly completely normal, or in remission. Although these evaluations were unblinded, clinicians frequently noted that the improvement was quite striking and gratifying to patients. Outcomes were reportedly sustained in 60% of those responding to
Financial disclosures
None.
Conflicts of interest
None.
References (19)
- et al.
Psychogenic movement disorders
Lancet Neurol
(2006 Aug) Psychogenic movement disorders
Semin Neurol
(2006 Jul)- et al.
Psychogenic tremor: long-term outcome
CNS Spectr
(2006 Jul) - et al.
Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study
Neuropsychiatry Neuropsychol Behav Neurol
(2001 Jul–Sep) - et al.
Psychogenic tremor and related disorders
J Neurol
(2007 May) - et al.
Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed disease
Mov Disord
(2009 Jan 15) Freud and psychogenic movement disorders
Treatment of psychogenic movement disorder: psychotrophic medications
Cited by (137)
Vestibular migraine and persistent postural perceptual dizziness
2024, Handbook of Clinical NeurologySensory Processing Difficulties in Patients with Functional Neurological Disorder: Occupational Therapy Management Strategies and Two Cases
2022, Seminars in Pediatric Neurology